BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1728614)

  • 1. Quantitative dot blot analyses of blood-group-related antigens in paired normal and malignant human breast tissues.
    Ura Y; Dion AS; Williams CJ; Olsen BD; Redfield ES; Ishida M; Herlyn M; Major PP
    Int J Cancer; 1992 Jan; 50(1):57-63. PubMed ID: 1728614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A, B, H, and Lewis-a and Lewis-b blood group antigens in human breast cancer: correlation with steroid hormone receptor and disease status.
    Idikio HA; Manickavel V
    J Cancer Res Clin Oncol; 1993; 119(8):486-92. PubMed ID: 8509439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human milk fat globule membrane glycoproteins express blood group-related determinants primarily on mucin-like epithelial membrane antigens and gp70.
    Dion AS; Williams CJ; Herlyn M; Major P
    Biochem Int; 1990 Oct; 22(2):295-302. PubMed ID: 1708665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lewis blood group antigens (a and b) in human breast tissues. Loss of Lewis-b in breast cancer cells and correlation with tumor grade.
    Idikio HA; Manickavel V
    Cancer; 1991 Sep; 68(6):1303-8. PubMed ID: 1651804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of fucosylated type 2 blood group chains in human breast and their significance.
    Walker RA; Day SJ
    J Pathol; 1986 Jun; 149(2):113-20. PubMed ID: 3734951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Lewisa, Lewisb, X, and Y blood group antigens in human colonic tumors and normal tissue and in human tumor-derived cell lines.
    Sakamoto J; Furukawa K; Cordon-Cardo C; Yin BW; Rettig WJ; Oettgen HF; Old LJ; Lloyd KO
    Cancer Res; 1986 Mar; 46(3):1553-61. PubMed ID: 3510728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer.
    Park C; Park K; Kim J; Sin Y; Park I; Cho H; Yang K; Bae BN; Kim KW; Ahn S; Gwak G
    World J Surg Oncol; 2016 Sep; 14(1):244. PubMed ID: 27619909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progesterone metabolites regulate induction, growth, and suppression of estrogen- and progesterone receptor-negative human breast cell tumors.
    Wiebe JP; Zhang G; Welch I; Cadieux-Pitre HA
    Breast Cancer Res; 2013 May; 15(3):R38. PubMed ID: 25927181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition with a monoclonal antibody of a cytoplasmic mammary carcinoma antigen, correlated to the estrogen receptor status.
    Krohn K; Helle M
    Int J Cancer; 1986 Jan; 37(1):43-7. PubMed ID: 3941021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Lewis(x), sialylated Lewis(x), Lewis(a), and sialylated Lewis(a) antigens in human lung carcinoma.
    Fukushima K
    Tohoku J Exp Med; 1991 Jan; 163(1):17-30. PubMed ID: 1675497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and Characterization of Novel Diagnostic Mouse Monoclonal Antibodies Against Human Estrogen Receptor Alpha and Progesterone Receptor.
    Hassanzadeh Makoui M; Mobini M; Khoshnoodi J; Judaki MA; Bahadori T; Ahmadi Zare H; Golsaz-Shirazi F; Moradi Tabriz H; Madjd Z; Jeddi-Tehrani M; Zarnani AH; Amiri MM; Shokri F
    Asian Pac J Cancer Prev; 2022 Sep; 23(9):2999-3007. PubMed ID: 36172662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoanatomic distribution of blood group antigens in the human urinary tract. Influence of secretor status.
    Cordon-Cardo C; Lloyd KO; Finstad CL; McGroarty ME; Reuter VE; Bander NH; Old LJ; Melamed MR
    Lab Invest; 1986 Oct; 55(4):444-54. PubMed ID: 2429066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood group and blood-group-related antigens in normal pancreas and pancreas cancer: enhanced expression of precursor type 1, Tn and sialyl-Tn in pancreas cancer.
    Schuessler MH; Pintado S; Welt S; Real FX; Xu M; Melamed MR; Lloyd KO; Oettgen HF
    Int J Cancer; 1991 Jan; 47(2):180-7. PubMed ID: 1988363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of blood group-related antigens, ABH, Lewis(a), Lewis(b), Lewis(x), Lewis(y), CA19-9, and CSLEX1 in early cancer, intestinal metaplasia, and uninvolved mucosa of the stomach.
    Murata K; Egami H; Shibata Y; Sakamoto K; Misumi A; Ogawa M
    Am J Clin Pathol; 1992 Jul; 98(1):67-75. PubMed ID: 1615929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABH and related histo-blood group antigens in normal & malignant human endometrium in relation to genetic and hormonal factors.
    Skovlund VR
    APMIS Suppl; 1997; 69():1-33. PubMed ID: 9254838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of blood group-related antigens in normal and malignant pancreatic tissue correlated with genotype of the patient defined by saliva glycoprotein.
    Ichihara T; Sakamoto J; Nakao A; Furukawa K; Watanabe T; Suzuki N; Horisawa M; Nagura H; Lloyd KO; Takagi H
    Cancer; 1993 Jan; 71(1):71-81. PubMed ID: 8416729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progesterone-independent effects of human progesterone receptors (PRs) in estrogen receptor-positive breast cancer: PR isoform-specific gene regulation and tumor biology.
    Jacobsen BM; Schittone SA; Richer JK; Horwitz KB
    Mol Endocrinol; 2005 Mar; 19(3):574-87. PubMed ID: 15563544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of analysis of estrogen and progesterone receptors in human uterine tissues].
    Maleeva A; Milkov V
    Akush Ginekol (Mosk); 1991 May; (5):55-7. PubMed ID: 1897675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistologic expression of blood-group antigens in normal human gastrointestinal tract and colonic carcinoma.
    Cordon-Cardo C; Lloyd KO; Sakamoto J; McGroarty ME; Old LJ; Melamed MR
    Int J Cancer; 1986 May; 37(5):667-76. PubMed ID: 3516890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological characteristics of luminal subtypes in pre- and postmenopausal estrogen receptor-positive and HER2-negative breast cancers.
    Murase K; Yanai A; Saito M; Imamura M; Miyagawa Y; Takatsuka Y; Inoue N; Ito T; Hirota S; Sasa M; Katagiri T; Fujimoto Y; Hatada T; Ichii S; Nishizaki T; Tomita N; Miyoshi Y
    Breast Cancer; 2014 Jan; 21(1):52-7. PubMed ID: 22359195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.